08/07/2024 3:31 PM | DiaMedica Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024 3:32 PM | DiaMedica Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/18/2024 11:15 PM | DiaMedica Therapeutics (Filer)
| Form EFFECT | |
07/18/2024 4:28 PM | DiaMedica Therapeutics (Filer)
| Form 424B3 | |
07/10/2024 3:16 PM | DiaMedica Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
07/08/2024 4:23 PM | DIALECTIC CAPITAL MANAGEMENT, LP (Filed by) DiaMedica Therapeutics (Subject)
| Form SC 13G | |
07/02/2024 1:25 PM | Daves Julie VanOrsdel (Reporting) DiaMedica Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
07/01/2024 3:24 PM | DiaMedica Therapeutics (Issuer) STAHLBERG JAN (Reporting) TRILL AB (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2024 7:16 AM | DiaMedica Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/26/2024 7:01 AM | DiaMedica Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/03/2024 3:41 PM | DiaMedica Therapeutics (Issuer) Pauls Dietrich John (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:29 PM | DiaMedica Therapeutics (Issuer) Pilnik Richard D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:35 PM | DiaMedica Therapeutics (Issuer) Semba Charles Pauling (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:09 PM | DiaMedica Therapeutics (Issuer) Kuntz Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 3:14 PM | DiaMedica Therapeutics (Issuer) Lewis Tanya (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:36 PM | DiaMedica Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/09/2024 11:15 PM | DiaMedica Therapeutics (Filer)
| Form EFFECT | |
04/04/2024 5:12 AM | DiaMedica Therapeutics (Filer)
| Form ARS | |
04/04/2024 5:05 AM | DiaMedica Therapeutics (Filer)
| Form DEF 14A | |
04/04/2024 5:06 AM | DiaMedica Therapeutics (Filer)
| Form DEFA14A | |
03/21/2024 3:47 PM | DiaMedica Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
01/23/2024 3:23 PM | DiaMedica Therapeutics (Issuer) Lorianne Masuoka K. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 4:00 PM | DiaMedica Therapeutics (Issuer) Kuntz Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 4:05 PM | DiaMedica Therapeutics (Issuer) Semba Charles Pauling (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:47 PM | DiaMedica Therapeutics (Issuer) Pilnik Richard D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:39 PM | DiaMedica Therapeutics (Issuer) Parsons James T. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 3:37 PM | DiaMedica Therapeutics (Issuer) Wambeke David J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |